GEN Exclusives

More »

GEN News Highlights

More »
Dec 7, 2009

GenOway to Provide Beth Israel Deaconess Medical Center with Transgenic Rodents

  • genOway has been signed up to provide the Beth Israel Deaconess Medical Center (BIDMC) with genetically modified rodents for its medical research. The deal takes the form of a two-year, renewable-framework agreement.

    genOway is a service provider dedicated to the development of genetically modified mouse and rat models. The company’s technologies include its Safe DNA Transgenesis™, Safe RNAi Transgenesis™, Safe in vivo RNAi™, and Quick Knock-in™ platforms.



Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

New Drugs for Ebola

Do you think that biopharma companies should not have to go through the normal drug approval process in order to get potential life-saving therapies to Ebola patients more quickly?